Publicis forecasts slower 2025, remains confident on outperformance - Reuters

Reuters | Feb. 4, 2025, 1:33 a.m. | Original
Publicis forecasts slower 2025, remains confident on outperformance Reuters
Novo Nordisk's next-gen obesity drug Cagrisema: investors seek answers - Reuters BNP Paribas beats Q4 forecast but trims 2025 profit target - Reuters